We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Skinbiotherapeutics Plc | LSE:SBTX | London | Ordinary Share | GB00BF33H870 | ORD 1P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
1.50 | 8.70% | 18.75 | 18.50 | 19.00 | 18.75 | 17.25 | 17.25 | 1,492,759 | 16:24:14 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Biological Pds,ex Diagnstics | 132k | -2.84M | -0.0125 | -15.00 | 39M |
Date | Subject | Author | Discuss |
---|---|---|---|
13/12/2024 12:16 | Always nice to see the little dummy trades take her back up for extensive selling | putinaire | |
13/12/2024 11:57 | Nice up for the day, despite some profit-taking for the last couple of days | master rsi | |
13/12/2024 11:21 | This is probably one of the important dates next year: " The formal, public launch of SkinBiotix as an active ingredient is to take place at In-Cosmetics Global, the world's largest cosmetic ingredients exhibition, in Amsterdam (April 8-10, 2025)." Read all about the event here: | netcurtains | |
13/12/2024 10:37 | Dude it can be anything you want it to be. Doesn't mean market will agree. It also does not mean you can't envisage otherwise. | putinaire | |
13/12/2024 09:50 | I found this in LinkedIn under one of the chemists employed by the company: "The most fascinating aspect in my opinion of chemistry is the knowledge that everything around us, the whole universe in fact, comprises a grand total of some 92 natural elements," This little company is going to be great. 😀 | netcurtains | |
13/12/2024 09:39 | Dont know what there is to ponder really. CRDA is known about for years. Market? Zero interest. Without a walk up to a liquidity price for dumping, averages about 6-10 gerbil trades per day Not exactly a market excited by prospects What's next? Market not aware? I assure you, it is now | putinaire | |
13/12/2024 09:36 | Probably call the police about a dodgy cold caller LOOOOL | putinaire | |
13/12/2024 09:35 | Its totally void of substance. Zero you can invest in. Grey . No relevant numbers. Tell you what. Take it to any desk in the city and ask them to invest. If not one of the hooky mincer seeder funds etc, tell ye to go do one | putinaire | |
13/12/2024 09:34 | I dont. you sound young. I am old. | netcurtains | |
13/12/2024 09:34 | i read statements like that daily dude, across the globe lol | putinaire | |
13/12/2024 09:32 | Read the statement: It seems relatively unlikely that SBTX will have a bad year in 2025... (I say relatively unlikely - in comparison with most of the AIM index). If you're going to gamble a few quid in AIM nothing better than a pharma that has signed a deal with a FTSE100 company and is expecting a good 2025. | netcurtains | |
13/12/2024 09:30 | Or they possibly have priced in the net earnings for crda and given the fact many think sbtx will be worth millions in revenues, they are booking in the big fkn loss in advance over there | putinaire | |
13/12/2024 09:27 | Looks like 'classified' is a voodoo word in the upper echelons | putinaire | |
13/12/2024 09:25 | Let's put it this way - croda been selling off since first mention of sbtx LOOOOL | putinaire | |
13/12/2024 09:24 | Yeah market is really impressed by that net. Truly, obviously ffs Maybe all that hs happened is some bigger guns became aware of sbtx via keyword 'crda' in their constant searches - and having a good laugh | putinaire | |
13/12/2024 09:23 | Nothing like maker keeping it in a dump range. But it was most impressive 50s/60s for months so opti could offload | putinaire | |
13/12/2024 09:23 | This is the important news This is croda the company: Croda has a market cap of £4b It is listed in FTSE100 It has a high PE ratio so needs big winners. | netcurtains | |
13/12/2024 08:53 | Ding dong... | netcurtains |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions